HUANG Mingyi),LIU Bin),HE Wei).Cancer testis antigen MAGE1 can induce immune response for antitumor in vivo and in vitro[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2013,(03):376.





Cancer testis antigen MAGE1 can induce immune response for antitumor in vivo and in vitro
1)河南中医学院 郑州 450046
2)郑州大学第一附属医院肿瘤科 郑州 450052
HUANG Mingyi1)LIU Bin1)HE Wei2)
1) Henan University of Traditional Chinese Medicine, Zhengzhou 450046
2) Department of Oncology, the First Affiliated Hospital,Zhengzhou University, Zhengzhou 450052
melanoma antigen1dendritic cellcytotoxic T lymphocyteimmunotherapyhepatic cellular cancermouse
摘要目的:探讨黑色素瘤抗原1(MAGE1)对特异性抗肝癌免疫应答反应的影响。方法:分别用转染pcDNA3.1MAGE1(重组子)、pcDNA3.1(空质粒)以及未行转染的人肝癌细胞SMMC7721冻融抗原致敏树突状细胞(DC),诱导T淋巴细胞增殖分化为细胞毒性T淋巴细胞(CTL)。乳酸脱氢酶释放法检测CTL对SMMC7721细胞的杀伤活性。48只C57BL小鼠随机分为重组子组、空质粒组和PBS组,每组16只。用pcDNA3.1MAGE1预先免疫重组子组小鼠,1次/10 d,第3次免疫后第5天ELISA法检测各组8只小鼠脾细胞培养液中IFNγ和IL2的含量,第6天各组8只小鼠接种鼠源性肝癌细胞H22,观察其生存时间。结果:未转染、空质粒和重组子组诱导的CTL对靶细胞的杀伤率以及各组小鼠股四头肌MAGE1 mRNA表达的比较差异有统计学意义(F=139.601和538.650,P﹤0.001),重组子组高于未转染和空质粒组。PBS组和空质粒组小鼠脾细胞培养液中IFNγ和IL2的含量为0,重组子组小鼠脾细胞培养液中IFNγ含量为(372.33±10.08) ng/L,IL2含量为(108.67±12.81) ng/L。3组小鼠荷瘤生存时间比较差异有统计学意义(F=31.837, P<0.001),重组子组小鼠生存时间明显延长。结论:MAGE1可诱导特异性抗肿瘤免疫应答,从而显著延长荷瘤小鼠的生存时间。
AbstractAim: To observe the immune antitumor function of MAGE1 in vivo and in vitro. Methods:Cytotoxic T lymphocytes(CTLs) were activated by DCs pulsed with freezethaw antigen of SMMC7721MAGE1 or SMMC7721pcDNA3.1(-) or wild type SMMC7721, respectively. Taking wild type SMMC7721 as target cells, the cytotoxicity of CTLs was detected by use of cytoTo nonradioactive cytotoxicity assay. pcDNA3.1MAGE1 was injected intramuscularly into C57BL mice on the 1st, 11th and 21st day with 100 μg/mouse, taking pcDNA3.1 and PBS as controls. On the 26th day, the volume of IL2 and IFNγ which were secreted by splenocytes was detected by ELISA. On the 27th day, the mice were inoculated mouse hepatoma H22 cells by celiac injection. The survival time of each mouse was recorded. Results: The expression of MAGE1 mRNA and the cytotoxicity of CTLs activated by DCs pulsed with freezethaw antigen of SMMC7721MAGE1 were higher than those of SMMC7721pcDNA3.1(-) group and SMMC7721 group(F=139.601 and 538.650,P<0.001). The contents of IL2 and IFNγ in pcDNA3.1MAGE1 group were (108.67±12.81) ng/L and (372.33±10.08) ng/L, respectively, while the contents of control groups were 0 ng/L. The survival time of pcDNA3.1MAGE1 group was (17.4±1.6) d, longer than those of the pcDNA3.1 group [(13.1±1.7) days] and the PBS group [(12.0±1.1) days](F=31.837, P<0.001). Conclusion: The pcDNA3.1MAGE1 DNA vaccine is able to induce cellular immune responses in vivo and in vitro.


[1]Bolhassani A, Yazdi SR. DNA immunization as an efficient strategy for vaccination[J]. Avicenna J Med Biotechnol, 2009,1(2):71
[2]Pereira CM, Gomes CC, De Fatima Correia Silva J, et al. Evaluation of MAGE A1 in oral squamous cell carcinoma[J]. Oncol Rep, 2012,27(6):1843
[3]Bao L, Dunham K, Lucas K. MAGEA1, MAGEA3, and NYESO1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocytemediated tumor cell killing[J]. Cancer Immunol Immunother, 2011,60(9):1299
[4]Karanikas V, Zamanakou M, Saukou F, et al. Naturally occurring tumorspecific CD8+ Tcell precursors in individuals with and without cancer[J]. Immunol Cell Biol, 2010,88(5):575
[5]Fang J, Wang G, Yang Q,et al. The potential of phage display virions expressing malignant tumor specific antigen MAGEA1 epitope in murine model[J]. Vaccine, 2005,23(40):4860
[6]Ma W, Vigneron N, Chapiro J,et al. A MAGEC2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy[J]. Int J Cancer, 2011,129(10):2427
[7]何炜, 张朝, 章茜, 等.真核表达载体pcDNA3.1MAGE1的构建[J]. 郑州大学学报:医学版, 2005,40(4):586
[8]郭妍,王菊芳,罗小春,等.多表达HBV重组DNA疫苗的构建与免疫效果评价[J]. 南方医科大学学报,26(12):1803
[9]Meek DW, Marcar L. MAGEA antigens as targets in tumour therapy[J]. Cancer Lett,2012,324(2):126
[10]Umeshappa CS, Huang H, Xie Y,et al. CD4+ ThAPC with acquired peptide/MHC class Ⅰ and Ⅱ complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses[J]. J Immunol, 2009,182(1):193
[11]Bijker MS, van den Eeden SJ, Franken KL,et al. Superior induction of antitumor CTL immunity by extended peptide vaccines involves prolonged, DCfocused antigen presentation[J]. Eur J Immunol, 2008,38(4):1033
[12]Munir S, Andersen GH, Met O, et al. HLArestricted CTL that are specific for the immune checkpoint ligand PDL1 occur with high frequency in cancer patients[J]. Cancer Res, 2013,73(6):1764


 LIU Kangdong),QIN Zhenzhu)),LU Jing),et al.Effects of highly metastatic colon carcinoma cell microenvironment on function of human dendritic cell[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2009,(03):1146.
 YUE Hesheng,ZHANG Dongyun.Effects of Jitai on function of dendritic cells derived from patients with chronic hepatitis B[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2009,(03):814.
 FENG Ting,ZHAO Mingyao,SUN Lisha,et al.Effects of achyranthes bidentata polysaccharide on antitumor ability of mouse bone marrowderived dendritic cells[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2010,(03):359.
 LV Fengshou),ZHAO Mingyao),JIANG Lili),et al.Influences of homogenate supernatant of human rectal carcinoma tissue on endothelialization of dentritic cells[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2010,(03):413.
[6]郝习),赵明耀),杨红艳),等. 枸杞多糖对荷H22肝腹水瘤小鼠免疫功能的影响[J].郑州大学学报(医学版),2011,(02):242.
 HAO Xi,ZHAO Mingyao,YANG Hongyan),et al. Effects of lycium barbarum polysaccharides on immune function of H22 tumor bearing mice[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2011,(03):242.
 SHAN Lei,HAO Jianwei,WANG Xiangyang.Effects of cytotoxicity T lymphocyte activated by dendritic cell loaded with LNCaP cell line frozenthawing antigen on LNCaP cell[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2012,(03):824.


*河南省基础与前沿技术研究计划资助项目122300410101 △女,1954年1月生,大学本科,教授,研究方向:肿瘤诊治,Email:huangmingyi2008@yahoo.cn
#通讯作者,男,1978年7月生,博士,副教授,研究方向:恶性肿瘤的综合治疗,Email: hewei726@126.com
更新日期/Last Update: 2013-07-03